1. Guided selection of antiplatelet therapy reduced rates of major adverse cardiovascular event rates compared to standard therapy.
2. Guided selection strategy was beneficial for both escalation and de-escalation of standard therapy, balancing patient-dependent ischemic and bleeding risks.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Patients who undergo percutaneous coronary intervention (PCI)...